Evaluate the Neurological Effects of EryDex on Subjects With A-T

NCT06193200 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

105

Enrollment

INDUSTRY

Sponsor class

Conditions

Ataxia Telangiectasia

Interventions

DRUG: Dexamethasone sodium phosphate
OTHER: Placebo

Sponsor

Quince Therapeutics S.p.A.

Collaborators

[object Object]